Latest News - Atopic Dermatitis

Thursday, May 17, 2018

Glenmark Pharmaceuticals Presents New Data on GBR 830, an Investigational, Anti-OX40 Monoclonal Antibody, at IID Meeting

Glenmark Pharmaceuticals shared data from a Phase 2a, proof-of-concept study of GBR 830, an investigational, anti-OX40 monoclonal antibody being studied for the treatment of moderate-to-severe atopic …

Read the full story

Wednesday, May 16, 2018

Dupixent Improves Moderate-to-Severe Atopic Dermatitis in Adolescents

DUPIXENT (dupilumab) performed well in a Phase 3 Trial of inadequately controlled moderate-to-severe atopic dermatitis in adolescents, Regeneron and Sanofi report. In the trial, treatment with…

Read the full story

Monday, May 07, 2018

Study Seeks to Harness the Power of Probiotics to Treat Eczema

A new clinical trial is investigating whether beneficial bacteria can help treat eczema by restoring the natural microbial balance of healthy skin. "There are over 1,000 species of bacteria th…

Read the full story

Wednesday, May 02, 2018

Bath Emollients Don’t Add Much to Standard Eczema Care

Emollient bath additives provide no meaningful benefit when used in addition to standard eczema care in children, according to research in the BMJ. UK researchers, led by Miriam Santer, MBBChi…

Read the full story

Tuesday, March 27, 2018

Skin of Color Society Reports Banner Year

Kudos to the Skin of Color Society (SOCS) for a banner year. At its recent annual business meeting held in conjunction with the 2018 Annual Meeting of the American Academy of Dermatology, SOCS…

Read the full story

Monday, March 19, 2018

Botanical Dermatology Brand Kamedis Forms U.S. Medical Advisory Board

Israeli-based Kamedis announced the formation of a U.S. medical advisory board. The members include: Zoe Draelos, MD, FAAD, a clinical and research dermatologist with a private solo practice in …

Read the full story

Friday, March 16, 2018

YouTube AD Videos Unreliable

Perhaps no surprise to dermatologists, new research reveals that one-third of YouTube videos about atopic dermatitis contain misleading information. That’s according to researchers from the Univ…

Read the full story

Monday, March 12, 2018

First Patient Dosed in Proof-of-Concept Trial of Topical by Design JAK Inhibitor SNA-125 for Atopic Dermatitis

The first patient has been dosed in Sienna Biopharmaceuticals, Inc.'s Phase 1/2 proof-of-concept clinical trial of topical product candidate SNA-125 in the treatment of atopic dermatitis and the a…

Read the full story

Friday, March 09, 2018

Newborn Skin May Pave the Way Toward New Eczema Lotion

Newborns emerge from the womb covered with a waxy substance called the vernix, which protects their skin from drying, and researchers have begun to realize that the vernix also helps babies adapt to l…

Read the full story

Thursday, March 08, 2018

Research Shines Light on Why People Experience AD in Winter

New research shows that the skin barrier is affected by climatic and seasonal changes. In tests of skin on 80 adults, the levels of breakdown products of filaggrin changed between winter and summer…

Read the full story

Tuesday, March 06, 2018

Medimetriks Divests Xepi Cream to Cutanea Life Sciences

Medimetriks Pharmaceuticals, Inc. divested exclusive US rights for Xepi (ozenoxacin cream) 1% to Cutanea Life Sciences, Inc. for up to $30 million, with $29 million to be paid in 2018, plus the assump…

Read the full story

Monday, March 05, 2018

Episciences Launches New Eczema Cream

Episciences, Inc. introduced a new Epionce Renewal Calming Cream, a formula that helps soothe as it replenishes moisture in the skin barrier. Renewal Calming Cream helps relieve the most stubborn symp…

Read the full story

Thursday, March 01, 2018

Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2018 Aspire Higher Scholarship Program

Ortho Dermatologics is accepting applications for the 2018 Aspire Higher scholarship program for students who have been affected by dermatologic conditions. Through the program, nine students will …

Read the full story

Monday, February 26, 2018

Burt’s Bees Nature-Based Sensitive Skin Regimen Trumps Dermatologist-recommended Regimen

Burt's Bees nature-based sensitive line outperformed a dermatologist-recommended synthetic control regimen in a study of 120 people with clinically diagnosed sensitive skin from rosacea, atopic de…

Read the full story

Friday, February 23, 2018

Galderma Enters into Long-term Research Agreement on AD with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine

Galderma has signed a joint research agreement on Atopic Dermatitis (AD) with two leading academic institutions -- Icahn School of Medicine at Mount Sinai in New York City, and Northwestern University…

Read the full story
Load More